MONARCH 2: Abemaciclib in Combination with Fulvestrant in Patients (pts) with Refractory Hormone Receptor Positive (HR plus )/Human Epidermal Growth Factor Receptor 2 Negative HER2-Advanced Breast Cancer (ABC) who Progressed on Endocrine Therapy (ET)

Affiliation auteurs!!!! Error affiliation !!!!
TitreMONARCH 2: Abemaciclib in Combination with Fulvestrant in Patients (pts) with Refractory Hormone Receptor Positive (HR plus )/Human Epidermal Growth Factor Receptor 2 Negative HER2-Advanced Breast Cancer (ABC) who Progressed on Endocrine Therapy (ET)
Type de publicationJournal Article
Year of Publication2018
AuteursSledge G.W, Toi M., Neven P., Sohn J.H, Inoue K., Pivot X., Burdaeva O., Okera M., Masuda N., Kaufman P.A, Koh H., Grischke E.M, Frenzel M., Lin Y., Barriga S., Smith I.C, Bourayou N., Llombart-Cussac A.
JournalONCOLOGY RESEARCH AND TREATMENT
Volume41
Pagination4
Type of ArticleMeeting Abstract
ISSN2296-5270